NLL Next Level Labs
CJC-1295 with DAC 5 MG research vial

RESEARCH COMPOUND

Currently testing new lot, COA on the way.FINRICK A · 7.5
View third-party Finrick COA

CJC-1295 with DAC

Long-acting GHRH analog with DAC for sustained IGF-1 elevation research.

$75/vial

VIAL FILL

5 MG

CLASS

GHRH analog (drug-affinity complex)

Download COA, PDF.
  • Test it yourself. If it does not match our Finrick COA, full refund and you keep the vial.
  • Pay by Venmo or Zelle, instructions emailed instantly.
  • Ships in 1 to 2 days.
99.90% This batch, HPLC
Finrick A · 7.5 Third-party HPLC
$10 · FREE $200+ USPS Priority Mail, US only

  • PURITY, THIS BATCH

    99.90%

  • BATCH

    New lot in QC

  • MOLECULAR WEIGHT

    CJC-1295 with DAC: 3,649.21 Da

  • SHIPPING

    US, USPS Priority Mail

For in vitro research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. US shipping only.

RESEARCH OVERVIEW

About this compound.

CJC-1295 with DAC is a synthetic growth hormone releasing hormone (GHRH) analog modified with a drug-affinity complex (DAC) that binds reversibly to serum albumin. The DAC modification extends the in vivo half-life from minutes to roughly 6 to 8 days, and is studied for prolonged elevation of GH and IGF-1 in animal models.

RECONSTITUTION + STORAGE

Lab handling.

RECONSTITUTION

Vials are lyophilized. Reconstitution and storage parameters should follow the recipient laboratory's standard protocols for peptide handling. Not for human consumption.

STORAGE

Lyophilized at room temp. Reconstituted, 2 to 8 degrees Celsius for up to 28 days.

RESEARCH CITATIONS

Research basis.

  • Teichman SL, et al. CJC-1295 prolonged GHRH analog, pharmacokinetics. J Clin Endocrinol Metab. 2006.
  • Ionescu M, et al. Pulsatile and sustained GH secretion with CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006.

Citations are listed for research context only and do not imply efficacy claims for human use.

FAQ

Common questions.

What does the DAC modification do?+

Drug-affinity complex binds reversibly to serum albumin, extending the half-life from minutes (native CJC-1295) to roughly 6 to 8 days in animal models.

How is this different from CJC-1295 + Ipamorelin?+

The Ipamorelin stack is a short-acting pulsatile pairing. CJC-1295 with DAC is studied as a long-acting GHRH baseline. They are different research tools.